Wed, November 1, 2023

Matthew Sykes Maintained (wgs) at Hold with Decreased Target to $6 on, Nov 1st, 2023

Matthew Sykes of Goldman Sachs, Maintained "GeneDx Holdings Corp." (WGS) at Hold with Decreased Target from $7 to $6 on, Nov 1st, 2023.

Matthew, nor any peers, have made any analyst calls on WGS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30